Assessing cerebral blood flow, oxygenation and cytochrome c oxidase stability in preterm infants during the first 3 days after birth

Ajay Rajaram, Daniel Milej, Marianne Suwalski, Lilian Kebaya, Matthew Kewin, Lawrence Yip, Sandrine de Ribaupierre, Victor Han, Mamadou Diop, Soume Bhattacharya, Keith St Lawrence, Ajay Rajaram, Daniel Milej, Marianne Suwalski, Lilian Kebaya, Matthew Kewin, Lawrence Yip, Sandrine de Ribaupierre, Victor Han, Mamadou Diop, Soume Bhattacharya, Keith St Lawrence

Abstract

A major concern with preterm birth is the risk of neurodevelopmental disability. Poor cerebral circulation leading to periods of hypoxia is believed to play a significant role in the etiology of preterm brain injury, with the first three days of life considered the period when the brain is most vulnerable. This study focused on monitoring cerebral perfusion and metabolism during the first 72 h after birth in preterm infants weighing less than 1500 g. Brain monitoring was performed by combining hyperspectral near-infrared spectroscopy to assess oxygen saturation and the oxidation state of cytochrome c oxidase (oxCCO), with diffuse correlation spectroscopy to monitor cerebral blood flow (CBF). In seven of eight patients, oxCCO remained independent of CBF, indicating adequate oxygen delivery despite any fluctuations in cerebral hemodynamics. In the remaining infant, a significant correlation between CBF and oxCCO was found during the monitoring periods on days 1 and 3. This infant also had the lowest baseline CBF, suggesting the impact of CBF instabilities on metabolism depends on the level of blood supply to the brain. In summary, this study demonstrated for the first time how continuous perfusion and metabolic monitoring can be achieved, opening the possibility to investigate if CBF/oxCCO monitoring could help identify preterm infants at risk of brain injury.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s).

Figures

Figure 1
Figure 1
(a) Time courses of relative cerebral blood flow (rCBF), tissue saturation (StO2), and change in the oxidation state of cytochrome c oxidase (ΔoxCCO) for one patient on the first day of life. (b) Corresponding frequency-time plots generated by wavelet transform of rCBF, StO2, and ΔoxCCO. The red box highlights the frequency band of notable CBF oscillation (0.001 to 0.005 Hz). The dotted white lines indicate the cone of influence. Wavelet values outside this region were considered distorted due to edge artefacts.
Figure 2
Figure 2
(a) Coherence between relative cerebral blood flow (rCBF) and tissue saturation (StO2), rCBF and oxidation state of cytochrome c oxidase (oxCCO), and StO2 and oxCCO for one patient on the first day of life. (b) Average coherence value in the frequency range 0.001 − 0.005 Hz [indicated by the red box in column (a)]. The red dashed line indicates the statistical threshold.
Figure 3
Figure 3
(a) Coherence between rCBF and StO2, rCBF and oxCCO, and StO2 and oxCCO for one patient on the first day of life. (b) Average coherence value in the frequency range 0.001−0.005 Hz. The red dashed line indicates the statistical threshold.
Figure 4
Figure 4
Boxplots of the fraction of time that coherence between two optical parameters reached the statistical threshold of 0.57. Data are presented separately for the two monitoring periods and for the three combinations of coherence estimates: rCBF/StO2, rCBF/ΔoxCCO and StO2/ΔoxCCO. Statistical outliers are indicated by + , and the bars indicate significant differences in coherence duration between rCBF/StO2 on day 1 and rCBF/ΔoxCCO on days 1 (p = 0.025) and 3 (p = 0.004). Details of each boxplot are as follows: rCBF/StO2 (day 1): median: 26.9, 75th percentile: 42.1, 25th percentile: 9.8; rCBF/StO2 (day 3): median: 16.6, 75th percentile: 27.5, 25th percentile: 11.5; rCBF/oxCCO (day 1): median: 11.0, 75th percentile: 17.0, 25th percentile: 5.5; rCBF/oxCCO (day 3): median: 8.3, 75th percentile: 10.4, 25th percentile: 4.0; StO2/oxCCO (day 1): median: 8.2; 75th percentile: 14.0; 25-th percentile: 4.9; and StO2/oxCCO (day 3): median: 10.3, 75th percentile: 14.1, 25th percentile: 5.6.
Figure 5
Figure 5
(a) Premature infant with optical probes secured to the forehead and a phototherapy eye shield, (b) schematic of probe holder showing the position of the NIRS (3-cm SDD) and DCS (2-cm SDD) sources and the common detection location (shaded circle). Probe holder was 5 × 2 × 1 cm.

References

    1. Nosarti C, et al. Adolescents who were born very preterm have decreased brain volumes. Brain. 2002;125:1616–1623. doi: 10.1093/brain/awf157.
    1. Stewart AL, et al. Ultrasound appearance of the brain in very preterm infants and neurodevelopmental outcome at 18 months of age. Arch. Dis. Child. 1983;58:598–604. doi: 10.1136/adc.58.8.598.
    1. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8:110–124. doi: 10.1016/S1474-4422(08)70294-1.
    1. Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin. Perinatol. 2009;36:737–762. doi: 10.1016/j.clp.2009.07.014.
    1. McCrea HJ, Ment LR. The diagnosis, management and postnatal prevention of IVH in the preterm neonate. Clin. Perinatol. 2010 doi: 10.1016/j.clp.2008.07.014.
    1. Vesoulis ZA, Mathur AM. Cerebral autoregulation, brain injury, and the transitioning premature infant. Front. Pediatr. 2017;5:64. doi: 10.3389/fped.2017.00064.
    1. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int. J. Dev. Neurosci. 2011;29:423–440. doi: 10.1016/j.ijdevneu.2011.02.012.
    1. Soul JS, et al. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr. Res. 2007;61:467–473. doi: 10.1203/pdr.0b013e31803237f6.
    1. Altman DI, et al. Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. Ann. Neurol. 1988;24:218–226. doi: 10.1002/ana.410240208.
    1. Greisen G, Andresen B, Plomgaard AM, Hyttel-Sørensen S. Cerebral oximetry in preterm infants: An agenda for research with a clear clinical goal. Neurophotonics. 2016;3:031407. doi: 10.1117/1.nph.3.3.031407.
    1. Wolf M, Greisen G. Advances in near-infrared spectroscopy to study the brain of the preterm and term neonate. Clin. Perinatol. 2009;36:807–834. doi: 10.1016/j.clp.2009.07.007.
    1. Dix LML, van Bel F, Lemmers PMA. Monitoring cerebral oxygenation in neonates: An update. Front. Pediatr. 2017 doi: 10.3389/fped.2017.00046.
    1. Pellicer A, et al. The SafeBoosC phase II randomised clinical trial: A treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants. Neonatology. 2013;104:171–178. doi: 10.1159/000351346.
    1. Plomgaard AM, et al. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life. Acta Paediatr. Int. J. Paediatr. 2019;108:275–281. doi: 10.1111/apa.14463.
    1. Hyttel-Sorensen S, Greisen G, Als-Nielsen B, Gluud C. Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants. Cochrane Database Syst. Rev. 2017 doi: 10.1002/14651858.CD011506.pub2.
    1. Kleiser S, et al. Comparison of tissue oximeters on a liquid phantom with adjustable optical properties: an extension. Biomed. Opt. Exp. 2018;9:86–101. doi: 10.1364/boe.9.000086.
    1. Boas DA, Franceschini MA. Haemoglobin oxygen saturation as a biomarker: the problem and a solution. Philos. Trans. A. Math. Phys. Eng. Sci. 2011;369:4407–4424. doi: 10.1098/rsta.2011.0250.
    1. Durduran T, Yodh AG. Diffuse correlation spectroscopy for non-invasive, micro-vascular cerebral blood flow measurement. Neuroimage. 2014;85(1):51–63. doi: 10.1016/j.neuroimage.2013.06.017.
    1. Roche-labarbe N, et al. Noninvasive optical measures of CBV, StO2, CBF index, and rCMRO2 in human premature neonates’ brains in the first six weeks of life. Hum. Brain Mapp. 2010;31:341–352. doi: 10.1002/hbm.20868.Noninvasive.
    1. Roche-Labarbe N, et al. Near-infrared spectroscopy assessment of cerebral oxygen metabolism in the developing premature brain. J. Cereb. Blood Flow Metab. 2012;32:481–488. doi: 10.1038/jcbfm.2011.145.
    1. Dehaes M, et al. Cerebral oxygen metabolism in neonatal hypoxic ischemic encephalopathy during and after therapeutic hypothermia. J. Cereb. Blood Flow Metab. 2014;34:87–94. doi: 10.1038/jcbfm.2013.165.
    1. Buckley EM, Parthasarathy AB, Grant PE, Yodh AG, Franceschini MA. Diffuse correlation spectroscopy for measurement of cerebral blood flow: future prospects. Neurophotonics. 2014;1:011009. doi: 10.1117/1.NPh.1.1.011009.
    1. Nourhashemi M, Mahmoudzadeh M, Goudjil S, Kongolo G, Wallois F. Neurovascular coupling in the developing neonatal brain at rest. Hum. Brain Mapp. 2020;41:503–519. doi: 10.1002/hbm.24818.
    1. Diop M, Kishimoto J, Toronov V, Lee DSC, St Lawrence K. Development of a combined broadband near-infrared and diffusion correlation system for monitoring cerebral blood flow and oxidative metabolism in preterm infants. Biomed. Opt. Exp. 2015;6:3907–3918. doi: 10.1364/BOE.6.003907.
    1. Lin PY, Hagan K, Fenoglio A, Grant PE, Franceschini MA. Reduced cerebral blood flow and oxygen metabolism in extremely preterm neonates with low-grade germinal matrix- intraventricular hemorrhage. Sci. Rep. 2016;1:1. doi: 10.1038/srep25903.
    1. Bale G, Elwell CE, Tachtsidis I. From Jöbsis to the present day: a review of clinical near-infrared spectroscopy measurements of cerebral cytochrome-c-oxidase. J. Biomed. Opt. 2016;21:091307. doi: 10.1117/1.JBO.21.9.091307.
    1. Cooper JA, et al. Continuous monitoring of absolute cerebral blood flow by near-infrared spectroscopy during global and focal temporary vessel occlusion. J. Appl. Physiol. 2011;110:1691–1698. doi: 10.1152/japplphysiol.01458.2010.
    1. Rajaram A, et al. Simultaneous monitoring of cerebral perfusion and cytochrome c oxidase by combining broadband near-infrared spectroscopy and diffuse correlation spectroscopy. Biomed. Opt. Exp. 2018;9:2588–2603. doi: 10.1364/BOE.9.002588.
    1. Rajaram A, et al. Optical monitoring of cerebral perfusion and metabolism in adults during cardiac surgery with cardiopulmonary bypass. Biomed. Opt. Exp. 2020;11:5967–5981. doi: 10.1364/boe.404101.
    1. Rajaram A, et al. Perfusion and metabolic neuromonitoring during ventricular taps in infants with post-hemorrhagic ventricular dilatation. Brain Sci. 2020;10:1–13. doi: 10.3390/brainsci10070452.
    1. Harvey-Jones K, Lange F, Tachtsidis I, Robertson NJ, Mitra S. Role of optical neuromonitoring in neonatal encephalopathy—current state and recent advances. Front. Pediatr. 2021;9:1–18. doi: 10.3389/fped.2021.653676.
    1. Milej D, et al. Characterizing dynamic cerebral vascular reactivity using a hybrid system combining time-resolved near-infrared and diffuse correlation spectroscopy. Biomed. Opt. Express. 2020;11:4571–4585. doi: 10.1364/boe.392113.
    1. Giovannella M. BabyLux device: A diffuse optical system integrating diffuse correlation spectroscopy and time-resolved near-infrared spectroscopy for the neuromonitoring of the premature newborn brain. Neurophotonics. 2019 doi: 10.1117/1.nph.6.2.025007.
    1. Bale G, et al. Oxygen dependency of mitochondrial metabolism indicates outcome of newborn brain injury. J. Cereb. Blood Flow Metab. 2018 doi: 10.1177/0271678X18777928.
    1. Jain V, et al. Cerebral oxygen metabolism in neonates with congenital heart disease quantified by MRI and optics. J. Cereb. Blood Flow Metab. 2014;34:380–388. doi: 10.1038/jcbfm.2013.214.
    1. Buckley EM, et al. Validation of diffuse correlation spectroscopic measurement of cerebral blood flow using phase-encoded velocity mapping magnetic resonance imaging. J. Biomed. Opt. 2012;17:037007. doi: 10.1117/1.JBO.17.3.037007.
    1. Giovannella M, et al. Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets. J. Cereb. Blood Flow Metab. 2020;40:2055–2065. doi: 10.1177/0271678X19883751.
    1. Diop M, Verdecchia K, Lee T-Y, St Lawrence K. Calibration of diffuse correlation spectroscopy with a time-resolved near-infrared technique to yield absolute cerebral blood flow measurements. Biomed. Opt. Exp. 2011;2:2068–2081. doi: 10.1364/BOE.2.002068.
    1. Noori S, McCoy M, Anderson MP, Ramji F, Seri I. Changes in cardiac function and cerebral blood flow in relation to peri/intraventricular hemorrhage in extremely preterm infants. J. Pediatr. 2014;164:264–270. doi: 10.1016/j.jpeds.2013.09.045.
    1. Alderliesten T, et al. Reference values of regional cerebral oxygen saturation during the first 3 days of life in preterm neonates. Pediatr. Res. 2016;79:55–64. doi: 10.1038/pr.2015.186.
    1. Buckley EM, et al. Cerebral hemodynamics in preterm infants during positional intervention measured with diffuse correlation spectroscopy and transcranial Doppler ultrasound. Opt. Exp. 2009;17:12571–12581. doi: 10.1364/OE.17.012571.
    1. Andresen B, et al. Cerebral oxygenation and blood flow in normal term infants at rest measured by a hybrid near-infrared device (BabyLux) Pediatr. Res. 2019 doi: 10.1038/s41390-019-0474-9.
    1. Diop M, Wright E, Toronov V, Lee T-Y, St Lawrence K. Improved light collection and wavelet de-noising enable quantification of cerebral blood flow and oxygen metabolism by a low-cost, off-the-shelf spectrometer. J. Biomed. Opt. 2014;19:057007. doi: 10.1117/1.JBO.19.5.057007.
    1. Kaynezhad P, et al. Quantification of the severity of hypoxic-ischemic brain injury in a neonatal preclinical model using measurements of cytochrome-c-oxidase from a miniature broadband-near-infrared spectroscopy system. Neurophotonics. 2019;6:1. doi: 10.1117/1.nph.6.4.045009.
    1. Cherian S, Whitelaw A, Thoresen M, Love S. The pathogenesis of neonatal post-hemorrhagic hydrocephalus. Brain Pathol. 2004;14:305–311. doi: 10.1111/j.1750-3639.2004.tb00069.x.
    1. Mertens L, et al. Targeted neonatal echocardiography in the neonatal intensive care unit: Practice guidelines and recommendations for training. Eur. J. Echocardiogr. 2011;24:1057–1078. doi: 10.1093/ejechocard/jer181.
    1. Selb J, et al. Sensitivity of near-infrared spectroscopy and diffuse correlation spectroscopy to brain hemodynamics: simulations and experimental findings during hypercapnia. Neurophotonics. 2014;1:015005. doi: 10.1117/1.NPh.1.1.015005.
    1. Khalid M, et al. Development of a stand-alone DCS system for monitoring absolute cerebral blood flow. Biomed. Opt. Exp. 2019;10:4607–4620. doi: 10.1364/boe.10.004607.
    1. Diop M, Wright E, Toronov V, Lee T-Y, St. Lawrence K. Improved light collection and wavelet de-noising enable quantification of cerebral blood flow and oxygen metabolism by a low-cost, off-the-shelf spectrometer. J. Biomed. Opt. 2014;19:057007. doi: 10.1117/1.JBO.19.5.057007.
    1. Kewin M, et al. Evaluation of hyperspectral NIRS for quantitative measurements of tissue oxygen saturation by comparison to time-resolved NIRS. Biomed. Opt. Exp. 2019;10:4789–4802. doi: 10.1364/BOE.10.004789.
    1. Duncan A, et al. Optical pathlength measurements on adult head, calf and forearm and the head of the newborn infant using phase resolved optical spectroscopy. Phys. Med. Biol. 1995;40:295–304. doi: 10.1088/0031-9155/40/2/007.
    1. Cheung C, Culver JP, Takahashi K, Greenberg JH, Yodh AG. In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies. Phys. Med. Biol. 2001 doi: 10.1088/0031-9155/46/8/302.
    1. Verdecchia K, Diop M, Morrison LB, Lee T-Y, St. Lawrence K. Assessment of the best flow model to characterize diffuse correlation spectroscopy data acquired directly on the brain. Biomed. Opt. Exp. 2015;6:4288. doi: 10.1364/boe.6.004288.
    1. Mendelson AA, et al. Dynamic tracking of microvascular hemoglobin content for continuous perfusion monitoring in the intensive care unit: Pilot feasibility study. J. Clin. Monit. Comput. 2020 doi: 10.1007/s10877-020-00611-x.
    1. Highton D, et al. Monitoring cerebral autoregulation after brain injury: Multimodal assessment of cerebral slow-wave oscillations using near-infrared spectroscopy. Anesth. Analg. 2015;121:198–205. doi: 10.1213/ANE.0000000000000790.
    1. Grinsted A, Moore JC, Jevrejeva S. Application of the cross wavelet transform and wavelet coherence to geophysical time series. Nonlinear Process. Geophys. 2004;11:561–566. doi: 10.5194/npg-11-515-2004.
    1. Scholkmann F, Spichtig S, Muehlemann T, Wolf M. How to detect and reduce movement artifacts in near-infrared imaging using moving standard deviation and spline interpolation. Physiol. Meas. 2010 doi: 10.1088/0967-3334/31/5/004.
    1. Beausoleil TP, Janaillac M, Barrington KJ, Lapointe A, Dehaes M. Cerebral oxygen saturation and peripheral perfusion in the extremely premature infant with intraventricular and/or pulmonary haemorrhage early in life. Sci. Rep. 2018;8:6511. doi: 10.1038/s41598-018-24836-8.
    1. Mitra S, et al. Pressure passivity of cerebral mitochondrial metabolism is associated with poor outcome following perinatal hypoxic ischemic brain injury. J. Cereb. Blood Flow Metab. 2019;39:118–130. doi: 10.1177/0271678X17733639.
    1. Chalak LF, et al. Novel wavelet real time analysis of neurovascular coupling in neonatal encephalopathy. Sci. Rep. 2017;7:45958. doi: 10.1038/srep45958.

Source: PubMed

3
Subskrybuj